These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8437650)

  • 1. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
    Erfurth A; Schmauss M
    Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
    Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
    J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment of obsessive-compulsive disorder: a review of findings in the light of diagnostic and metric limitations.
    Towbin KE; Leckman JF; Cohen DJ
    Psychiatr Dev; 1987; 5(1):25-50. PubMed ID: 2885832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open trial of MAO inhibitors in bulimia.
    Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH
    J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of obsessive-compulsive disorder with depression responsive to trazodone.
    Baxter LR
    J Nerv Ment Dis; 1985 Jul; 173(7):432-3. PubMed ID: 4009160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MAO-(monoamine oxidase-)inhibitor plus lithium. 1. Choice in psychopathologic rapidly changing bipolar manic-depressive patients (rapid cyclers)].
    Rogan M; Lesch OM; Schjerve M; Musalek M; Walter H
    Wien Klin Wochenschr; 1983 Jul; 95(14):498-502. PubMed ID: 6636782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers.
    Beckmann H; Moises HW
    Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965
    [No Abstract]   [Full Text] [Related]  

  • 15. THREE EVALUATIONS OF A MONOAMINE OXIDASE INHIBITOR AND PHENOTHIAZINE COMBINATION (A METHODOLOGICAL AND CLINICAL STUDY).
    WINKELMANN W
    Dis Nerv Syst; 1965 Mar; 26():160-4. PubMed ID: 14262229
    [No Abstract]   [Full Text] [Related]  

  • 16. Moclobemide response in obsessive-compulsive disorder.
    al Jeshi A
    Can J Psychiatry; 1999 Apr; 44(3):285. PubMed ID: 10225134
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid antidepressant effect of addition of lithium to tranylcypromine.
    Tariot PN; Murphy DL; Sunderland T; Mueller EA; Cohen RM
    J Clin Psychopharmacol; 1986 Jun; 6(3):165-7. PubMed ID: 3711366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Afternoon fatigue and somnolence associated with tranylcypromine treatment.
    Joffe RT
    J Clin Psychiatry; 1990 May; 51(5):192-3. PubMed ID: 2335494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MAO inhibitors and depressive disorders today].
    Bonamy D; Olié JP; Lôo H
    Encephale; 1983; 9(2):123-36. PubMed ID: 6641614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.